Elekta a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, announced that The University of Texas MD Anderson Cancer Center has signed a deal with company to acquire Elekta Infinity linear accelerators, brachytherapy afterloaders as well as software and service.
Bill Yaeger, Elekta’s executive vice president, Region North America, says: “As a world-renowned cancer center, MD Anderson has been a technology leader in managing the disease. In addition to being one of the first US medical centers to acquire Elekta’s new Leksell Gamma Knife Icon brain radiosurgery system, MD Anderson is also part of the consortium to develop the world’s first high-field MR-guided linear accelerator. We are proud that it has chosen us again in the expansion of its facilities in Texas. Both organizations share a commitment to quality and the best care possible for patients.”
The order, for four Infinity treatment systems, will also include Elekta’s high-resolution beam shaping solution, the Agility 160-leaf multi-leaf collimator.
The deal also includes four high-dose-rate (HDR) brachytherapy afterloaders and Oncentra Brachy treatment planning; MOSAIQ Oncology Information System (OIS); Active Breathing Coordinator units; as well as service for the hardware and software.